Viewing Study NCT01338103


Ignite Creation Date: 2025-12-24 @ 7:38 PM
Ignite Modification Date: 2025-12-30 @ 5:33 AM
Study NCT ID: NCT01338103
Status: UNKNOWN
Last Update Posted: 2011-05-02
First Post: 2011-04-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Treatment of Pemphigus Patients With Rituximab 1000mgX2 and Assessment of Immune Status Via Cylex
Sponsor: Rabin Medical Center
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 5474
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: Daniel Mimouni MD
Old Organization: Rabin Medical Center, Department of Dermatology

Collaborators

Collaborators

Name Class View
None OTHER View